Table 2 Comparison of fatigue scores of the case and control groups measured using VAFS and FSS questionnaires using independent t-test.
From: A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
Fatigue scoring scales | Before treatment (Mean ± SD) | After treatment (Mean ± SD) | Difference between before and after treatment (Mean ± SD) |
|---|---|---|---|
VAFS | |||
Amantadine group | 7.90 ± 0.60 | 3.37 ± 0.44 | 4.53 ± 0.44 |
Control group | 7.34 ± 0.58 | 5.97 ± 0.29 | 1.37 ± 0.13 |
P-value | 0.087 | < 0.001 | < 0.001 |
FSS | |||
Amantadine group | 53.10 ± 5.96 | 28.40 ± 2.42 | 24.70 ± 7.20 |
Control group | 50.38 ± 4.88 | 42.59 ± 1.50 | 7.79 ± 0.86 |
P-value | 0.053 | < 0.001 | < 0.001 |
